Type 2 diabetes is a complex chronic disease that occurs when the body cannot produce enough insulin or use it effectively. People with type 2 diabetes need treatment to keep their insulin and blood sugar levels under control. Insulin is a hormone produced by the pancreas that controls the amount of glucose in the blood. A lack of insulin means the body cannot absorb glucose from the food we eat. When this happens Blood glucose levels rise, and over time, these increased levels can damage blood vessels and reduce the supply of oxygen and nutrient-rich blood to the body's organs and nerves. People with type 2 diabetes, whose bodies don't respond well to or are resistant to insulin, may need treatment to help their bodies process glucose better. This can help prevent long-term complications. Scientists work every day to improve treatment options for people with type 2 diabetes. We spare no effort to help, from providing the most effective medications to how they are taken. Our scientists have a simple goal: to find unmet needs in chronic diseases and turn them into new therapeutic solutions. One such idea is to develop a treatment for type 2 diabetes that is either injectable or oral. This treatment had been a goal for many years, but the challenge lay in the body's digestive system. Once ingested, biologic drugs, such as insulin, are digested by enzymes in the body, much like food is digested. Scientists needed to find a way to pass biologic drugs through the digestive system unchanged so they could enter the bloodstream. Scientists have recently succeeded in showing that a synthetic version of the glucagon-like peptide-1 hormone (GLP-1) can be taken. It is naturally produced in the intestines and is secreted in response to food consumed. release It comes in tablet form. GLP-1 is produced GLP-1Insulin secretion is stimulated in the pancreas, which again reduces the amount of glucose in the blood. This is the world's first oral treatment for type 2 diabetes using a GLP-1 receptor agonist. Scientists hope to soon offer a wider range of oral treatments, not only for diabetes, but also for other serious chronic diseases in our research group. For nearly 100 years, scientists have been discovering new ways to inject insulin. This has been driven by our commitment to making the process of distributing the medication as simple and convenient as possible. Our starting point is with people living with type 2 diabetes. We learn about the difficulties they face with self-medication and how to make treatment safer and easier. We use scientific methods from anthropology to biochemistry to provide data and guidance to enhance our research, engineering, and expertise skills. Al-Mustaqbal University is the first university in Iraq.
  الهدف الثالث من اهداف التنمية المستدامة -الصحة الجيدة والرفاه